Drug Screening Market Size 2022 | Segmentation, Outlook, Industry Report to 2032
The global drug screening market size is projected to expand at a 16% CAGR from US$ 5.3 Bn in 2021 to US$ 18 Bn by 2032 showing an immense improvement.
“Teenage illicit alcohol usage, rising road accidents owing to a drug overdose while driving, and prescription medication abuse are predicted to fuel market revenue growth.”
The rise in regulatory approvals for the drug screening laboratory services market is ascribed to increased drug and alcohol usage and the implementation of rigorous legislation demanding alcohol and drug test. Bans on alcohol use in Islamic nations and limitations on an occupational drug test in select countries, on the other hand, may limit the market’s growth to some extent.
What is the COVID-19 Impact on Drug Screening Market?
Covid-19 pandemic resulted in a worldwide restriction on the movement of people and led to the isolation of individuals in their own homes. This is the primary reason for the drop in demand for drug screening services as most of the workplaces were shut down, and healthcare resources were diverted to take care of covid-19 patients. Trade restrictions also had a similar negative impact on equipment availability for drug screening procedures.
But with the covid-19 situation getting controlled and commercial activities returning to customary conditions, the drug testing industry is predicted to revive gradually and speed up during the forecast period.
What are the Drivers, Restraints, Opportunities, & Threats in the Drug Screening Market?
“The development of improved screening technology and growing awareness of the benefits of alcohol or drug screening are creating business opportunities.”
Drug misuse and alcohol usage are on the rise all around the world. According to the World Drug Report 2021, 275 million persons aged 15–64, or one out of every 18 people in that age group, took drugs at least once in the preceding year (range: 175 million to 374 million).
Drug use problems were expected to affect 36.3 million individuals worldwide, accounting for over 13% of the global population. Drug use killed about half a million individuals in the same year, and drug use disorders resulted in the loss of 18 million years of a healthy life, primarily owing to opioids.
Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14265
Similar increases in alcohol intake have been seen, with the resultant rise in the prevalence of impaired driving. Development of drug screening products and services on the road, boosting the total market growth.
Which Drivers are Limiting the Drug Screening Adoption?
Alcohol and drug tests in the workplace are considered a breach of employee privacy in certain nations, including Canada, Colombia, Argentina, Chile, and South Africa. In France, for example, pre-employment saliva drug testing is only done when doctors prescribe it.
Workplace alcohol and drug tests are illegal in Poland and the Czech Republic. In Canada, Eastern Canadian case laws allow alcohol and immunoassay drug tests only where occupational activities are fundamentally risky or when alcohol and drug testing is confined to a few specific circumstances.
What are the Opportunities for the Drug Screening Market?
Disruptions in the global supply chain, diminished demand, and client suspensions have all been experienced by companies in the drug screening sector. The test examines microscopic amounts of perspiration in the fingerprint to identify drugs and drug metabolites. This test might eventually replace urine, hair, and blood-based immunoassay drug test.
Although fingerprint-based swab drug test can help prevent the spread of COVID, it is non-invasive, portable, time-saving, and sanitary, allows for social distance, is user-friendly, and requires no unique sample collection or handling preparation.
This test is simple to administer whenever and wherever needed, making it ideal for workplace drug testing. To identify drugs and drug metabolites, at home drug test examines microscopic amounts of perspiration in the fingerprint. Workplaces, criminal justice, police enforcement, and drug recovery programs employ this test, which are offering opportunities to the market players.
Drug screening market future trends appear optimistic, with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories.
Fingerprint-based drug testing is a new concept that has gained traction and is one of the emerging trends in the drug screening market as a result of and impact of the COVID-19 on the drug screening market. Due to the risk of spreading the infection, the coronavirus has made it challenging to conduct drug testing in hospitals, labs, and other facilities.
Although fingerprint-based drug screening can aid in controlling COVID, it is portable, less time-consuming, and hygienic, allows for social distancing, is user-friendly, and requires no special preparation for sample collection and handling. This test is simple to implement wherever required, making it ideal for effective and flexible workplace drug testing.
The test analyses small traces of sweat in the fingerprint to detect drugs and drug metabolites. If widely used, this test is expected to replace urine, hair, and blood-based drug tests. This can be considered as one of the significant drug screening market key trends & opportunities to capitalize on and ramp up the adoption of drug screening devices etc.,
Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-14265
Alere, Inc. invented the xReader, a point-of-care testing device for workplace drug testing. The following year, the company created the Alere iCup Rx Drug Screen to detect commonly misused and abused prescription drugs. Furthermore, recent developments in the drug screening are expected to garner considerable revenue share and surge the sales of drug screening devices in the near future.
Illicit drug abuse is a global social and health issue, and illicit drug monitoring use is critical in the context of public policies. It is already known that analysis of residual urban waters can yield relevant epidemiologic data.
This drug screening method, known as wastewater-based epidemiology (WBE), is based on measuring specific markers produced by human biotransformation of the target drugs as indicators of compound consumption by the population served by the wastewater treatment installation under investigation.
Factors such as an increase in alcohol consumption among youth and the elderly population, overuse of prescribed drugs, and an increase in the use of narcotics and illicit drive the growth of the drug screening market.
Furthermore, increased competition among manufacturers fuels the growth of the drug discovery screening market. Manufacturers are developing innovative products in broader categories to gain a larger drug screening market share.
Which are the Major Drug Screening Market Segments?
The product and services for the drug screening laboratory services market are categorized into drug screening products, analytical instruments, rapid testing devices, consumables, and drug screening services. Analytical Instruments are primarily in breathalyzers, immunoassay analyzers, and chromatography instruments. Semiconductor breathalyzers have experienced increased sales in recent years as it is easy to use outdoors by law enforcement agencies. The other type of breathalyzer is the fuel cell breathalyzer.
Rapid testing devices have started gaining importance for drug monitoring programs and are predicted to overtake the global drug screening market in the coming years. This segment is further classified according to devices such as urine testing devices and oral fluid testing devices. The urine drug test devices occupy a significant share in the market in terms of volume due to the requirement of associated equipment like drug testing cups, dip cards, and drug testing cassettes.
Consumables are a recent development in the immunoassay drug test market, which is performed using assay kits, sample collection devices and calibrators & controls.
Who is the Major End User in the Drug Screening Market?
According to applications of various products and services for drug screening and development, the market caters to different end-users, namely drug testing laboratories, workplaces, criminal justice and law enforcement agencies, hospitals, drug treatment centers, pain management centers, schools and colleges, and other individual users.
Despite the development of innovative drug screening methods, drug testing laboratories and hospitals will remain the significant consumers for products of the drug screening market.
How has the Different Methods of Sample Collection Shaped the Drug Screening Market?
The sample type collected for the drug discovery screening market is classified according to urine samples, breath samples, oral fluid samples, hair samples, and other samples.
Traditionally, urine samples and breadth samples are the most used drug screening methods in different setups. Mouth swab or saliva drug tests have emerged as a widely used method after the covid-19 pandemic and promises to gain popularity in the coming years.
What is the Regional Analysis of the Drug Screening Market?
A detailed analysis of the drug screening services provided by companies across the corporates, clubs, healthcare facilities informs us about the prospect market growth across all major economies, including North America (US, Canada, and the rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Benelux, Nordic Countries and the rest of Europe), Middle East and Africa (GCC Countries, South Africa, Turkey, and rest of Middle East) and the Asia Pacific (China, Japan, South Korea and the other Pacific countries).
According to the market survey, North America holds the largest share at 48.2% of the globe. As there has been an increase in consumption of illicit drugs by citizens of North American Countries and the government increasingly investing in curbing drug abuse by establishing drug screening laboratory services market, the region is expected to experience considerable growth in the years ahead.
The growing burden of drunk and drive cases is also becoming a significant factor in law enforcement agencies’ growing demand for drug screening. Additionally, most of the primary critical players present in the North American drug screening market and adjoining areas have always favoured the colossal market volume.
Who are the Key Players in the Drug Screening Market?
The key players in the market include Labcorp, Quest Diagnostics, Abbott Laboratories, Orasure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG & CO, Lifeloc Technologies, MPD Inc., and Omega Laboratories.
Market players rely on the use of innovative technologies to derive efficiency into the drug screening kits and devices and get a hold of a better position in the drug screening market. In addition to this, the focus has also been on inorganic growth to get the benefit of collaboration and mutual growth.
Some of the other competitive players in the market for drug screening services are Laboratory Corporation of America Holdings, Hoffmann -La Roche Ltd, BioMerieux SA, Express Diagnostics Int’l, Inc., Bio-Rad Laboratories Inc., Biomedical Diagnostics, Danaher, Synergy Health plc., Agilent Technologies, Shimadzu Medical Pvt. Ltd., Alere Inc., Premier Biotech, Inc., Psychemedics Corporation, Siemens Healthineers Private Limited, American Bio Medica Corporation, Sciteck, Inc., ACM Global Laboratories., CareHealth America, and Clinical Reference Laboratory, Inc.
Recent Developments in Drug Screening Market:
- The Omega Hair 17-panel drug test can detect multiple psychoactive substances, particularly benzodiazepines. It was developed by Omega laboratories and was introduced in 2018.
- Detection of any ingestion of Marijuana, CBD and nicotine drugs by a vaping panel test was introduced by Psychemedics.
- Two US companies named Infirmary Health and LabCorp have agreed to offer laboratory testing services in the countries of the Eastern Gulf Coast.
Another Agreement was signed between Quest Diagnostics and Select Health of South Carolina to expand their laboratory network.
Key Segments
By Sample Type:
- Urine samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By Product and Service:
- Drug screening
- Analytical Instruments
- Rapid Testing Devices
- Consumables
- Drug Screening Service
By End User:
- Drug Testing Laboratories
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools and Colleges
- Workplaces
By Region:
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East & Africa
Top Related Reports Healthcare Market Insights
https://wakelet.com/wake/rRrxxZmy06MnT0NzGIWAl
https://kaalama.org/read-blog/179765
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
Editor Details
-
Company:
- MARKITWIRED
- Website:
